Michael Jahnz:制药工业废水零有害物质排放的检测和净化策略

作者:本网编辑 文章来源:PHT《制药业》 发布时间:2017-06-08
Michael Jahnz,WESSLING(上海)控股有限公司高级经理...

Michael Jahnz,WESSLING(上海)控股有限公司高级经理

杨麦克

现在工作在维斯聆环保信息咨询(上海)有限公司,拥有14年工作经验。曾任职于拜耳(中国)、诺克松制药股份公司、斯克里普斯研究所,La Jolla,是英国威尔士卡迪夫大学工商管理硕士,马克斯普郎克生物物理化学研究所生化科学博士,汉诺威医科大学生物化学硕士

ENGLISH:

Michael Jahnz is working in Wessling Shanghai branch company currently. He has 14 years work experience and once worked in Bayer China (Limited) Shanghai, NOXXON Pharma AG and the Scripps Research Institute (TSRI).He is the MBA of university of Wales Cardiff, PhD in life-science of Max-Planck-Institute for Biophysical Chemistry , and has diploma in biochemistry of University of Hannover and Hannover Medical School.

 

演讲摘要

制药工业废水零有害物质排放的检测和净化策略

近年来,纺织业,鞋业,和其他消费行业越来越关注于环境保护,并在其制造流程中加强了环保措施。与此同时,制药业也面临类似的压力。演讲主旨为介绍药品生产过程中产生的废水及其危害,新型的更精密的探测方法,各国不同的检测标准,以及净化策略。

ENGLISH:

Testing and Purification Strategies towards Zero-Discharge in Pharma Industry Wastewater

In recent years, the textile, footwear and other consumer industries developed a strong focus on environment protection and made much effort to clean up their whole manufacturing chain. A similar pressure is now on pharmaceutical industry. This talk focus on pharmaceutical wastewater and sheds light on problematic wastewater pollutants, new sensitive testing methods, the status of national testing standards, and also shows some treatment options.

0
-1
收藏